Lisa Wilson | IR |
Brian Markison | Chairman, President & CEO |
James Schaub | Executive VP & COO |
Andrew Einhorn | CFO |
David Jacobs | Head of Clinical Development and Medical Affairs |
David Steinberg | Jefferies |
David Maris | Wells Fargo |
Dan Busby | RBC Capital Markets |
Emily Field | Barclays |
Good day, ladies and gentlemen, and welcome to the Osmotica 2018 Business Update Call. At this time all participants are in a listen-only mode. [Operator Instructions] As a reminder, today's conference may be recorded. I'd now like to introduce your host for today's conference, Lisa Wilson, Investor Relations for Osmotica Pharmaceuticals. Ma'am, please go ahead.